Potent and orally bioavailable stearoyl-CoA desaturase (SCD) inhibitors for the potential treatment of obesity and diabetes

被引:0
|
作者
Koltun, Dmitry [1 ]
Parkhilll, Eric Q. [1 ]
Vasilevich, Natalya I. [2 ]
Glushkov, Andrei I. [2 ]
Zilbershtein, Timur M. [2 ]
Ivanov, Aleksey V. [2 ]
Zautke, Nathan A. [3 ]
Brunn, Sandra A. [3 ]
Mollova, Nevena [4 ]
Leung, Kwan [4 ]
Chisholm, Jeffrey W. [3 ]
Zablocki, Jeff [5 ]
机构
[1] CV Therapeut, Dept Bioorgan Chem, Palo Alto, CA 94304 USA
[2] ASINEX Ltd, Dept Chem, Moscow 123367, Russia
[3] CV Therapeut, Dept Pharmacol Sci, Palo Alto, CA 94304 USA
[4] CV Therapeut, Dept Preclin Dev, Palo Alto, CA 94304 USA
[5] CV Therapeut, Dept Med Chem, Palo Alto, CA 94304 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
4-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Pioglitazone increases Stearoyl-CoA desaturase (SCD) gene expression and protein levels in humans
    Rassouli, Negah
    Yao-Borengasser, Aiwei
    Varma, Vijayalakshmi
    Bodles, Angela M.
    Phanavanh, Bounleut
    Rasouli, Neda
    Kern, Philip A.
    DIABETES, 2007, 56 : A356 - A356
  • [42] Stearoyl-CoA desaturase-1 inhibitors: Discovery and in vivo evaluation
    Liu, Gang
    Xin, Zhili
    Zhao, Hongyu
    Serby, Michael D.
    Smith, Harriet T.
    Cao, Ning
    Surowy, Teresa K.
    Adler, Andrew
    Mika, Amanda
    Farb, Thomas B.
    Keegan, Cheryl
    Landschulz, Kathy
    Brune, Michael
    Collins, Christine A.
    Sham, Hing L.
    Camp, Heidi S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 525 - 525
  • [43] Characterization of five single nucleotide polymorphisms in the porcine stearoyl-CoA desaturase (SCD) gene
    Ren, J
    Knorr, C
    Guo, YM
    Ding, NS
    Ai, HS
    Brenig, B
    Huang, LS
    ANIMAL GENETICS, 2004, 35 (03) : 255 - 257
  • [44] Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
    Tracz-Gaszewska, Zuzanna
    Dobrzyn, Pawel
    CANCERS, 2019, 11 (07)
  • [45] Conversion of systemically-distributed triazole-based stearoyl-CoA desaturase (SCD) uHTS hits into liver-targeted SCD inhibitors
    Leclerc, Jean-Philippe
    Falgueyret, Jean-Pierre
    Girardin, Melina
    Guay, Jocelyne
    Guiral, Sebastien
    Huang, Zheng
    Li, Chun Sing
    Oballa, Renata
    Ramtohul, Yeeman K.
    Skorey, Kathryn
    Tawa, Paul
    Wang, Hao
    Zhang, Lei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) : 6505 - 6509
  • [46] The role of stearoyl-CoA desaturase 1 in the development of obesity related insulin resistance
    Jazurek, Magdalena
    Dobrzyn, Pawel
    Szerbart, Anna
    Ntambi, James M.
    Dobrzyn, Agnieszka
    CHEMISTRY AND PHYSICS OF LIPIDS, 2010, 163 : S60 - S60
  • [47] Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors
    Isabel, Elise
    Powell, David A.
    Black, W. Cameron
    Chan, Chi-Chung
    Crane, Sheldon
    Gordon, Robert
    Guay, Jocelyne
    Guiral, Sebastien
    Huang, Zheng
    Robichaud, Joel
    Skorey, Kathryn
    Tawa, Paul
    Xu, Lijing
    Zhang, Lei
    Oballa, Renata
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 479 - 483
  • [48] Scd3 -: A novel gene of the stearoyl-CoA desaturase family with restricted expression in skin
    Zheng, Y
    Prouty, SM
    Harmon, A
    Sundberg, JP
    Stenn, KS
    Parimoo, S
    GENOMICS, 2001, 71 (02) : 182 - 191
  • [49] Leptin and the control of metabolism: Role for stearoyl-CoA desaturase-1 (SCD-1)
    Cohen, P
    Friedman, JM
    JOURNAL OF NUTRITION, 2004, 134 (09): : 2455S - 2463S
  • [50] Investigation of the gene expression pattern and the regulation of stearoyl-CoA desaturase 5 (SCD5)
    Zambo, V.
    Szabo, L.
    Csala, M.
    Kereszturi, E.
    FEBS OPEN BIO, 2021, 11 : 106 - 107